Exane Derivatives’s Hubbell HUBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$186K Sell
1,040
-88
-8% -$16.6K 0.11% 175
2022
Q1
$207K Sell
1,128
-182
-14% -$34.2K 0.06% 323
2021
Q4
$273K Buy
1,310
+135
+11% +$27K 0.07% 280
2021
Q3
$212K Buy
1,175
+135
+13% +$26.3K 0.05% 383
2021
Q2
$196K Buy
+1,040
New +$196K 0.04% 400

Other funds holding HUBB

Exane Derivatives's HUBB Position: Q2 2022 in Review

Exane Derivatives reduced its Hubbell (HUBB) stake by 7.8% in Q2 2022, selling an estimated $16.6K and leaving 1,040 shares worth $186K. The position accounts for 0.11% of the portfolio, ranked #175.

Exane Derivatives first reported a position in HUBB in Q2 2021 and has held it in 5 quarters since. The position peaked at $273K in Q4 2021. 468 funds tracked by Wall St. Rank hold HUBB as of Q2 2022.

  • Exane Derivatives held 1,040 shares of Hubbell worth $186K as of Q2 2022.
  • Exane Derivatives sold 88 Hubbell shares in Q2 2022, an estimated $16.6K.
  • Hubbell made up 0.11% of Exane Derivatives's portfolio in Q2 2022, its #175 holding.
  • Exane Derivatives first reported a position in Hubbell in Q2 2021 and has held it in 5 quarters since.
  • Exane Derivatives's Hubbell position peaked at $273K in Q4 2021.
  • 468 funds tracked by Wall St. Rank held Hubbell as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.